The Big Molecule Watch is monitoring clinical trial activities involving adalimumab. Here we report on three recent studies with adalimumab biosimilars for treating psoriasis, inflammatory bowel disease, Crohn’s disease and ulcerative colitis. In July 2022, clinical trial data was published from a real-life retrospective observational study of pediatric (<18 years)…
